June 2018 ARTICLE LIST >>
PharmaTutor (June - 2018)
ISSN: 2347 - 7881
(Volume 6, Issue 6)
Received On: 18/04/2018; Accepted On: 17/05/2018; Published On: 01/06/2018
AUTHORS:
Vinoth Kumar P1, Rajalakshmi AN 1*, Stephen P 2
1 Department of Pharmaceutics, College Of Pharmacy,
Mother Theresa Postgraduate and Research Institute of Health Sciences,
Puducherry, India
2 Formulation Research and Development,
SaiMirra Innopharm Pvt Ltd., Chennai, Tamil Nadu, India
*ocusertraji@gmail.com
ABSTRACT
Orodispersible liquisolid system is the combination of liquisolid technique and orodispersible system. The poor dissolution rate of water insoluble drug is a major drawback for the development of pharmaceutical dosage forms. The oral absorption of drug is most often controlled by dissolution in the gastrointestinal tract. Liquisolid system has been used to enhance dissolution rate of poorly water-soluble drugs. Orodispersible tablets are given in order to provide fast action by disperse in the mouth, without the need of water and make them compliance for paediatric and geriatric patients and to bypass the liver metabolism.
How to cite this article: Vinoth P, Rajalakshmi AN, Stephen P; Orodispersible liquisolid compacts: A novel approach to enhance solubility and bioavailability; PharmaTutor; 2018; 6(6); 28-35; http://dx.doi.org/10.29161/PT.v6.i6.2018.28
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Abdul Hasan Sathali A., Deepa C (2013); “Formulation of liquisolid tablets of candesartan cilexetil”; Int. J. Res. Pharm. Sci; 4(2); 238-249.
2. Amrit B., Karmarkar Indrajeet D.,Gonjari., Avinash H Hosmani., Pandurang N Dhabale., Satish B Bhise (2009); “Liquisolid Tablets: A Novel Approach for Drug Delivery; International Journal of Health Research”; 2(1); 45-50.
3. Bhise SB., Nighute AB., Yadav AV., Yadav VB (2009); “Aceclofenac size enlargement by non aqueous granulation with improved solubility and dissolution”; Arch Pharm Sci & Res; 1; 115-122.
4 .Chang RK., Guo X., Burnside BA., Cough RA (2002); “Fast dissolving tablets”; Pharm Tech; 24(6); 52-58.
5. Dokoumetzidis A., & Macheras P (2006); A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system; International journal of pharmaceutics; 321(1-2); 1-11.
6. Gubbi S.R., Jarag R (2009); “Liquisolid Technique for enhancement of dissolution properties of Bromhexine Hydrochloride”; Research J. Pharm. And Tech; 2(2); 382-386.
7. Hamsanandini J., Parthiban S., Vikneswari A., Sentil kumar G.P., Tamiz Mani T (2015); “Formulation and Evaluation of Orodispersible Liquisolid Compacts of Meloxicam using Banana Powder as a Natural Superdisintegrants”; Asian Journal of Research in Biological and Pharmaceutical Sciences; 3(1); 25-38.
8. Javadzadeh Y., Nokhodchi A (2008); “Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine)”; Int J Pharm; 341(1-2); 26-34.
9. Kaushik D., Dureja H., Saini TR (2004); “Mouth dissolving tablets: A Review”; Indian Drugs; 41(4): 187-193.
10. Kumar S., Gupta SK., Sharma PK (2012); “A Review on Recent Trends in Oral Drug Delivery-Fast Dissolving Formulation Technology”; Adv Biol Res; 6(1); 6-13.
11. Mudgal VK, Singhai AK et al (2011); “Orally Disintegrating tablet: A Review”; International Research Journal of pharmacy; 2(4); 16-22.
12. Munke AP., Nagarsenker MS (2004); “Triamterene β-cyclodextrin systems: Preparation, characterization and In vivo evaluation”; AAPS PharmSciTech; 5(1); E19.
13. Nazzal S., Khan MA (2006); “Controlled release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters”; Int. J. Pharm; 2006; 315(1-2); 110-121.
14. Reddy M., Babu S., Harshita B., Sravya R (2012); “Conventional and Patented Technologies in Oral Dispersible Tablets: A Review”; J Chem Pharm Sci; 6(4); 286-92.
15. Saharan V (2009); “Dissolution enhancement of drugs. Part I: technologies and effect of carriers”; Int. J. Health Res; 2(2); 107-124.
16. Sambasiva AR., Naga TA (2011); “Liquisolid Technology: An Overview”; Int J Res Pharma Biomed Sci; 2(2); 401-409.
17. Shashidher B., Veera R (2012); “Formulation and evaluation of carvedilol liquisolid tablets”; African Journal of Pharmaceutical Sciences and Pharmacy; 3(1); 30-44.
18. Shu T, Suzuki H, Hironaka K, Ito K (2002); “Studies of rapidly disintegrating tablets in oral cavity using co-ground mixture of mannitol with crospovidone”; Chemical & Pharmaceutical Bulletin; 50(2); 193-198.
19. Spireas S (2002); “Liquisolid Systems and Methods of Preparing Same”; U.S. Patent 6423339 B1; 2002.
20. Spireas S., Bolton M (1999); “Liquisolid Systems and Methods of Preparing Same”; U.S. Patent 5968.1999; 550.
21. Spireas S., Sadu S (1998); “Enhancement of prednisolone dissolution properties using liquisolid compacts”; Int. J.Pharm; 166(2); 177-188.
22. Tayel SA., Soliman II., Louis D (2008); “Improvement of Dissolution Properties of Carbamazepine through Application of the Liquisolid Technique”; Eur J Pharm Biopharm; 69(1); 342-347
23. Velmurugan S., Vinushitha S (2010); “Oral Disintegrating Tablets: An Overview”; International Journal of Chemical and Pharmaceutical Sciences; 1(2); 1-12.
24. Vijaykumar Nagabandi., Ramarao T., Jayaveera K.N (2011); “Liquisolid Compacts: A Novel Approach to Enhance Bioavailability of Poorly Soluble Drugs”; International Journal of Pharmacy and Biological Sciences; 1(3); 89-102.
25. Yadav A.V., Shete A.S., Dabke A.P (2010); “Formulation and Evaluation of Orodispersible Liquisolid Compacts of Aceclofenac”; Indian Journal of Pharmaceutical Education and Research; 44(3); 227-235
26. Yadav VB, Yadav AV (2009); “Liquisolid granulation technique for tablet manufacturing: an overview”; Journal of Pharmacy Research; 2(4); 670-674.
.png)
